echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Six changes of the official two vote system in Guangdong

    Six changes of the official two vote system in Guangdong

    • Last Update: 2017-11-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: the two vote system of Guangdong Province, which attracted the attention of medical observer.com on November 8, 2017, has hit the ground today! On November 7, the author obtained a notice of two vote system scheme (Trial) for drug trade in medical institutions jointly issued by eight departments including Guangdong Provincial Department of human resources and social security The notice was officially issued on November 2, 2017 So far, from January 9, 2017, when the 8 ministries and commissions officially announced the implementation plan, in 10 months, the basic dust of the two vote system in all parts of the country has been settled In general, Guangdong's two vote system has absorbed the opinions of pharmaceutical manufacturers, commercial circulation enterprises and other parties, and the overall policy is more rational and soft than the draft 1、 The definition of "two ticket system" refers to that the pharmaceutical manufacturers issue one invoice to the pharmaceutical circulation enterprises and the pharmaceutical circulation enterprises issue one invoice to the medical institutions Compared with the draft, "distribution enterprise" is replaced by "distribution enterprise" 2、 It is emphasized that in the new two vote system of relative holding, a wholly-owned or controlled commercial company (only one commercial company in China) established by a pharmaceutical manufacturer or a group enterprise integrating science, industry and trade that only sells its own (Group) pharmaceuticals can be regarded as a manufacturing enterprise Compared with the draft for comments, the formal draft does not have the requirement of "a wholly-owned (or holding more than 50%) commercial company established by a pharmaceutical manufacturer or a group enterprise integrated with science, industry and trade that only sells the pharmaceuticals of the enterprise (Group)", no longer emphasizes absolute holding, but emphasizes relative holding, which is more in line with the actual commercial needs 3、 The internal allocation of circulation group enterprises does not count as one vote The internal allocation of drugs between circulation group enterprises and wholly-owned (holding) subsidiaries may not be regarded as one vote, but the invoice can be issued at most once Compared with the draft, "transfer of drugs among wholly-owned subsidiaries within the drug distribution group" has been quietly deleted 4、 Pharmaceutical enterprises can entrust circulation enterprises to upload sales invoices According to the new two ticket system, drug manufacturers should upload or entrust drug distribution enterprises to upload the invoices of selling drugs to the drug trading platform within 5 working days after the invoice is issued Compared with the simple requirement of "the manufacturer must submit the invoices of selling drugs to the provincial trading platform" in the draft, the workload of the manufacturers is greatly reduced and the pressure of uploading the invoices is greatly reduced The forces are shared layer by layer However, at the same time, the formal draft requires that invoices be verified level by level according to the clear distribution chain of each party on the provincial trading platform, i.e the next level verifies the next level, the next level verifies the next level, and relevant information is confirmed on the system after it is verified to be correct before entering the next level of transaction The relevant bills of the trading parties in the purchase and sale of drugs shall still be kept for future reference in accordance with the relevant provisions That is to say, if the business thinks that the invoice of the pharmaceutical enterprise is unqualified, it will not confirm the order, and the business will not take the risk of confirming the invoice that does not meet the requirements, to bear the risk of the medical institution's ticket inspection problem or even return, which is also the actual situation that the production enterprise must take into account 5、 The transition period is 6 months The new two vote system shows that the transition period is 6 months During the transitional period, drug manufacturers should fully consider the original distribution channels of medical institutions and other factors, and re select the drug distribution enterprises that confirm the relevant varieties on the drug trading platform Drug distribution enterprises should properly handle the drugs in stock that do not meet the two vote system If the medical institution has signed the drug purchase and sale contract that has not been completed, it can continue to implement the contract until the end of the transitional period After the transition period, the drug purchase and sale contract should strictly implement the two vote system It's not hard to see that the six-month transition time is basically enough for businesses, pharmaceutical companies and hospitals to adjust their sales (distribution) structure and make a new layout In fact, even though Guangdong's two vote system has not come out yet, under the situation that the national two vote system has almost swept across, pharmaceutical enterprises that are determined to sell in Guangdong's pharmaceutical market have already made up their minds 6、 Strange, no more emphasis on Shenzhen Guangdong GPO! A week ago, I got the internal news of Guangdong's two vote system: Shenzhen and Guangzhou, two places that carry out GPO procurement, should adhere to the two vote system, which can be implemented in combination with their own situation However, as soon as the official draft is published, the two regional words of GPO in Shenzhen and Guangzhou have disappeared Of course, the official draft still emphasizes that all public medical institutions in the province implement the two vote system in drug procurement, and encourage private hospitals to implement the two vote system in drug procurement If so, it means that Shenzhen and Guangzhou will still be included in the scope of provincial public medical institutions, and continue to carry out the two vote system according to the pace of the province.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.